Why Haven't We Cloned a Woolly Mammoth Yet?

Cloning a woolly mammoth hasn’t happened yet largely because the key biological ingredients needed for a successful birth—especially intact mammoth cells and a workable way to obtain and use Asian elephant eggs—remain unresolved. The breakthrough that sparked renewed hope came from a well-preserved Siberian carcass nicknamed “Buttercup,” which was reported to contain “red fluid” that might have been blood. If even a single intact cell nucleus existed inside those red blood cells, researchers could theoretically insert it into an elephant egg and use a surrogate Asian elephant to carry the embryo.

That promise hit a major roadblock in 2014 when scientists reported they found no such red blood cells in the specimen. Even if a future carcass does contain intact nuclei, the next bottleneck is even more practical: how to retrieve elephant eggs, combine them with mammoth DNA, and then implant the fertilized egg. While transferring a nucleus between cells is routine in laboratories, the transcript emphasizes that the full chain of steps required to create a living animal is far harder—starting with obtaining eggs in the first place.

Because classic cloning depends on usable mammoth cells, researchers are also exploring a different route: genome editing. The idea is to build mammoth DNA traits directly into living elephants rather than relying on recovered mammoth cells. Traits under consideration include hair characteristics, ear shape, and subcutaneous fat—features that would help a genetically modified elephant survive in icy tundra conditions. A proposed workflow starts with inserting edited genetic code into Asian elephant stem cells, growing them into lab-grown organoids, and then using the edited genome in an elephant egg. If development and birth succeed, the result would likely be a hybrid: not a pure woolly mammoth, but an elephant carrying mammoth adaptations.

The potential payoff extends beyond a headline “Jurassic Park” moment. Reintroducing mammoth-like animals to the tundra could, in theory, help slow climate warming. The transcript points to research suggesting that large animals’ foraging exposes grass buried under snow, which keeps the ground colder. Colder ground helps preserve permafrost and reduces the release of CO2 trapped within it.

Timing remains speculative. Some groups have floated dates as early as 2018, including efforts associated with Harvard and Sinogene Biotech (described as cloning dogs for $100,000). But ethical and biological uncertainties loom, especially because elephants are highly intelligent and social. Questions include how elephants would respond to experimental procedures and whether a hybrid offspring would be accepted by elephant groups.

Historical cloning results offer mixed guidance. Dolly the sheep, the first successfully cloned animal (born in 1996), suffered severe health problems and died at six. Yet a later 2016 study cloning 13 sheep reported no signs of poor health, suggesting Dolly may have been an outlier. The transcript also notes that other “extinct” cloning attempts have struggled: in 2009, researchers announced a cloned Pyrenean ibex, but it died shortly after birth due to lung defects. Together, these examples underline the same theme: even with the right DNA, making a healthy animal is the hardest part.